Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT05931666 |
| Other study ID # |
RIPHAH/RCRS/REC/Letter-01400 |
| Secondary ID |
|
| Status |
Completed |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
June 1, 2022 |
| Est. completion date |
June 22, 2023 |
Study information
| Verified date |
July 2023 |
| Source |
Riphah International University |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
The aim of this research is to determine the effects of Gong mobilization and Kaltenborn
mobilization in patients of frozen shoulder. This is a Randomized clinical trial. The sample
size is 40. The subjects are divided in two groups, with 20 subjects in Group A and 20
subjects in Group B. Study duration is of 6 months. Sampling technique applied is
Nonprobability Purposive Sampling. Both males and females of aged 40-65 years with Stage-II
frozen shoulder are included. Tools used in the study are Visual Analogue Scale (VAS),
Goniometer, and SPADI (Shoulder pain and disability index) questionnaire.
Description:
Adhesive capsulitis or periarthritis, more commonly termed as frozen shoulder is a
pathological process where adhesions are formed across glenohumeral joint causing
debilitating pain and movement restrictions. The pathology is categorized as primary, being
idiopathic and occur spontaneously without any inciting event, or secondary which occur as a
result of some identifiable disorder such as diabetes mellitus (where a cascade of
inflammatory reactions, collagen build-up and other extracellular components lead to tendon
fibrosis and dysfunction, presenting as diabetic frozen shoulder) or some other inciting
event. The incidence of frozen shoulder is evident to be 3-5% in general population while
it's up to 20% in diabetic patients. Further it is more evident in females aged 40-60 years.
Moreover frozen shoulder is classified into four stages which include Stage-I characterized
by painful shoulder at rest and disturbed sleep, lasting up to 3 months; Stage-II termed the
"freezing stage" is identified by chronic pain along with restrictions in range of motion
(ROM) and last up to 9 months; Stage-III called the "frozen stage" where a considerable
reduction in ROM and a rigid end feel is observed and occurs during 9 to 15 months of onset;
Stage-IV is "thawing phase" where ROM improves progressively, as frozen shoulder is a
self-limiting condition and lasts from 15 to 24 months.
The standard exercise protocol followed for management of frozen shoulder include active and
active assisted exercises, Codman exercises, wall and ladder exercises, wand exercises,
capsular stretching, and shoulder joint mobilization. The electrotherapeutic modalities
employed include ultrasound to resolve inflammation, interferential therapy and
transcutaneous electrical nerve stimulation (TENS) for pain control and thermal therapy to
relieve pain and improve muscles extensibility.
Manual therapy techniques of mobilization have been proved to be very effective in treating
frozen shoulder. The Gong's mobilization technique which combines the concepts of distraction
and Maitland, is explained as end range mobilization where an antero-posterior glide is
applied in dynamic position of the shoulder joint followed by distraction and performance of
the restricted movement. The technique serves to reduce pain and improve range of motion and
is significant in producing immediate effects. Kaltenborn mobilization technique depends on
concave rule and gives grades of traction which include loosening, tightening and stretching
of the soft connective tissues.
